Clinical Trial Update: Mesalazine Therapy in Patients With Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating mesalazine therapy in patients with irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: SOFAR S.p.A. | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED